Jeevan Therapeutics

Built by patients and drug developers, Jeevan Therapeutics is a seed-stage biotech in Cambridge developing next-generation medicines for colon-associated diseases. Our lead program for Crohn’s disease is a first-in-class, dual-targeting bispecific nanobody designed to block migration and eliminate the pathogenic cells that drive relapse, with the goal of achieving durable, long-term remission. Alongside this program, we are advancing a broader pipeline of precision biologics and novel therapeutic modalities with potential to address multiple autoimmune conditions where current treatments fall short.